SPRO
Spero Therapeutics, Inc. · Healthcare
Aquilo Capital Management, LLC bought $1.4M of Spero Therapeutics, Inc.
10% owner
Bought$1,448,263
$11.59Price
125,000Shares
+2%Stake
What SPRO did for a copier
- $1,000 copied at Wed, Feb 2 open, $11.37
- $731
- S&P 500, same days
- −3.2%
Measured over 30 trading days, to the Mar 17 close.
Aquilo Capital Management, LLC's record
12 other buys with 3 months of prices since 2021: on average −56.7% against the S&P 500, and 0 of 12 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Jan 31. Filed Tue, Feb 1, 8:26 PM ET, after the close. Returns use the Feb 2 open and the Mar 17 close. Not investment advice.